These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7419340)

  • 1. The effect of levodopa with carbidopa (Sinemet R) on the metabolic response to semistarvation.
    Jung RT; Liddell F; Shetty PS; James WP
    Int J Obes; 1980; 4(3):221-6. PubMed ID: 7419340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of catecholamine replacement with levodopa on the metabolic response to semistarvation.
    Shetty PS; Jung RT; James WP
    Lancet; 1979 Jan; 1(8107):77-9. PubMed ID: 84131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of catecholamine replacement on the metabolic response to semistarvation.
    Shetty PS; Jung RT; Barrand M; Callingham BA; James WP
    Proc Nutr Soc; 1979 May; 38(1):18A. PubMed ID: 461440
    [No Abstract]   [Full Text] [Related]  

  • 4. A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100).
    Cedarbaum JM; Kutt H; McDowell FH
    Neurology; 1989 Nov; 39(11 Suppl 2):38-44; discussion 59. PubMed ID: 2586762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting metabolic rate, body composition and thyroid hormones. Short term effects of very low calorie diet.
    Cavallo E; Armellini F; Zamboni M; Vicentini R; Milani MP; Bosello O
    Horm Metab Res; 1990 Dec; 22(12):632-5. PubMed ID: 2076860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period.
    Quinn N; Parkes D; Janota I; Marsden CD
    Mov Disord; 1986; 1(1):65-8. PubMed ID: 3504233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations.
    Jankovic J; Schwartz K; Vander Linden C
    Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short and long term effects of a very low calorie diet on resting metabolic rate and body composition.
    Vansant G; Van Gaal L; Van Acker K; De Leeuw I
    Int J Obes; 1989; 13 Suppl 2():87-9. PubMed ID: 2613433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
    Wilke WL
    Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta-adrenergic blockade on metabolic rate and peripheral thyroid metabolism in obesity.
    Jung RT; Shetty PS; James WP
    Eur J Clin Invest; 1980 Jun; 10(3):179-82. PubMed ID: 6111457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.
    Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC
    Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of Sinemet and bromocriptine.
    Eames P
    Brain Inj; 1989; 3(3):319-22. PubMed ID: 2758194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of parkinsonism by L-dopa and dopa-decarboxylase inhibitor in a single tablet].
    Sarova-Pinhas I; Braham J
    Harefuah; 1974 Sep; 87(5):208-10. PubMed ID: 4435614
    [No Abstract]   [Full Text] [Related]  

  • 18. Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration.
    Raftopoulos C; Dethy S; Laute MA; Goldman S; Naini AB; Przedborski S; Hildebrand J
    Mov Disord; 1996 Jan; 11(1):59-62. PubMed ID: 8771068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does metabolic compensation explain the majority of less-than-expected weight loss in obese adults during a short-term severe diet and exercise intervention?
    Byrne NM; Wood RE; Schutz Y; Hills AP
    Int J Obes (Lond); 2012 Nov; 36(11):1472-8. PubMed ID: 22825659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinemet and thyroid function in Parkinson disease.
    Wingert TD; Hershman JM
    Neurology; 1979 Jul; 29(7):1073-4. PubMed ID: 572939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.